Aptadel Therapeutics — Seed (estimated) · approximately €480K

The US Little Warrior Foundation put $500K (about €480K) into Aptadel to strengthen its Ewing sarcoma programme. It was the foundation's first investment outside the US, and it joined the company's shareholders. The company's own news page dates the announcement 24 January 2025. At the time Aptadel said it planned a further €1.5M raise, which it later closed as the €2M bridge round of 2026.